AIMCA
CNCE

Alberta Investment Management Corp (AIMCo)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,700
Closed -$329K – 840
2017
Q4 		$329K Buy
+12,700
New +$256K ﹤0.01% 677

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s CNCE Position: Q1 2018 in Review

Alberta Investment Management Corp (AIMCo) sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2018, closing a stake of 12,700 shares — an estimated $329K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in CNCE in Q4 2017 and held it in 1 quarter. The position peaked at $329K in Q4 2017. 123 funds tracked by Wall St. Rank hold CNCE as of Q1 2018.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 12,700 Concert Pharmaceuticals, Inc. shares in Q1 2018, an estimated $329K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Concert Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Concert Pharmaceuticals, Inc. position peaked at $329K in Q4 2017.
  • 123 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2018.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2018, filed 16 May 2018.